DK0539492T3 - Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner - Google Patents

Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner

Info

Publication number
DK0539492T3
DK0539492T3 DK91913698T DK91913698T DK0539492T3 DK 0539492 T3 DK0539492 T3 DK 0539492T3 DK 91913698 T DK91913698 T DK 91913698T DK 91913698 T DK91913698 T DK 91913698T DK 0539492 T3 DK0539492 T3 DK 0539492T3
Authority
DK
Denmark
Prior art keywords
antigenic
meningitidis
akin
toxins
iron
Prior art date
Application number
DK91913698T
Other languages
English (en)
Inventor
Frederick Sparling P
Alan Thompson Stuart
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of DK0539492T3 publication Critical patent/DK0539492T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK91913698T 1990-07-16 1991-07-16 Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner DK0539492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55264990A 1990-07-16 1990-07-16
PCT/US1991/005014 WO1992001460A1 (en) 1990-07-16 1991-07-16 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins

Publications (1)

Publication Number Publication Date
DK0539492T3 true DK0539492T3 (da) 2003-09-22

Family

ID=24206214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913698T DK0539492T3 (da) 1990-07-16 1991-07-16 Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner

Country Status (9)

Country Link
EP (2) EP0539492B1 (da)
JP (2) JP3329452B2 (da)
AT (1) ATE242784T1 (da)
AU (1) AU8298991A (da)
CA (1) CA2087160A1 (da)
DE (1) DE69133276T2 (da)
DK (1) DK0539492T3 (da)
ES (1) ES2202297T3 (da)
WO (1) WO1992001460A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO2000034482A2 (en) * 1998-12-08 2000-06-15 Smithkline Beecham Biologicals S.A. Novel compounds derived from neisseria meningitidis
WO2000042193A1 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
US8409587B2 (en) 2002-11-01 2013-04-02 Glaxosmithkline Biologicals S.A. Immunogenic composition
EP1667712B1 (en) 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. B. pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
CA2792683A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Neisserial fhbp vaccine composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine

Also Published As

Publication number Publication date
EP0539492A1 (en) 1993-05-05
CA2087160A1 (en) 1992-01-17
EP0539492A4 (en) 1993-09-01
DE69133276D1 (de) 2003-07-17
ATE242784T1 (de) 2003-06-15
JP2002233390A (ja) 2002-08-20
DE69133276T2 (de) 2003-11-27
JPH06502394A (ja) 1994-03-17
AU8298991A (en) 1992-02-18
WO1992001460A1 (en) 1992-02-06
EP1338607A2 (en) 2003-08-27
EP0539492B1 (en) 2003-06-11
JP3329452B2 (ja) 2002-09-30
EP1338607A3 (en) 2004-08-18
ES2202297T3 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
DK0539492T3 (da) Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner
AP2001002199A0 (en) Novel streptococcus antigens
DE69534872D1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
ATE194844T1 (de) Hepatitis c-virus-epitope
DE69737125D1 (de) Streptococcus pneumoniae antigene und impfstoffe
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
ATE524194T1 (de) Antigene polypeptide
NO870412D0 (no) Peptider.
DK0498851T3 (da) Tumorassocieret urinantigen, anvendelse af antigene underenheder og fremgangsmåder til detektion
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
EP0303983A3 (en) Synthetic peptides, antibodies directed against them and their use
NO923781D0 (no) Ekspresjon av heterologt protein i gjaer
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
ZA872711B (en) Affinity chromatography material and its use in the separation and purification of protein antigens of the bacteria of the bordetella genus
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
ATE266090T1 (de) Gegen mumps impfstoff, das ein virus des jeryl- lynn stammes enthält
IL139495A0 (en) Moraxella catarrhalis proteins
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens